OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies
Lea Skak Filtenborg Frederiksen, Yibang Zhang, Camilla Foged, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 275

Showing 1-25 of 275 citing articles:

COVID-19 vaccines
Duduzile Ndwandwe, Charles Shey Wiysonge
Current Opinion in Immunology (2021) Vol. 71, pp. 111-116
Open Access | Times Cited: 345

Attitudes, acceptance and hesitancy among the general population worldwide to receive the COVID-19 vaccines and their contributing factors: A systematic review
Fidelia Cascini, Ana Pantović, Yazan A. Al‐Ajlouni, et al.
EClinicalMedicine (2021) Vol. 40, pp. 101113-101113
Open Access | Times Cited: 345

Healthcare workers’ (HCWs) attitudes and related factors towards COVID-19 vaccination: a rapid systematic review
Mei Li, Yue Luo, Roger Watson, et al.
Postgraduate Medical Journal (2021) Vol. 99, Iss. 1172, pp. 520-528
Closed Access | Times Cited: 215

Prevalence of anxiety symptom and depressive symptom among college students during COVID-19 pandemic: A meta-analysis
Jun-Jie Chang, Yan Ji, Yonghan Li, et al.
Journal of Affective Disorders (2021) Vol. 292, pp. 242-254
Open Access | Times Cited: 205

Optimal levels of vaccination to reduce COVID-19 infected individuals and deaths: A global analysis
Mario Coccia
Environmental Research (2021) Vol. 204, pp. 112314-112314
Open Access | Times Cited: 178

Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines
Basmah N. Aldosari, Iman M. Alfagih, Alanood S. Almurshedi
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 206-206
Open Access | Times Cited: 170

An overview of current COVID-19 vaccine platforms
Abdou Nagy, Bader Y. Alhatlani
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 2508-2517
Open Access | Times Cited: 152

A systematic literature review to clarify the concept of vaccine hesitancy
Daphne Bussink-Voorend, Jeannine L.A. Hautvast, Lisa Vandeberg, et al.
Nature Human Behaviour (2022) Vol. 6, Iss. 12, pp. 1634-1648
Open Access | Times Cited: 135

Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities
Majed Ghattas, Garima Dwivedi, Marc Lavertu, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1490-1490
Open Access | Times Cited: 113

COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: Review of available evidence
Sarah Wack, Timothy Patton, Laura K. Ferris
Journal of the American Academy of Dermatology (2021) Vol. 85, Iss. 5, pp. 1274-1284
Open Access | Times Cited: 109

An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times
Cielo García‐Montero, Óscar Fraile-Martínez, Coral Bravo, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 433-433
Open Access | Times Cited: 103

Willingness of Ethiopian Population to Receive COVID-19 Vaccine
Yitayeh Belsti, Yibeltal Yismaw Gela, Yonas Akalu, et al.
Journal of Multidisciplinary Healthcare (2021) Vol. Volume 14, pp. 1233-1243
Open Access | Times Cited: 101

A comprehensive review on COVID-19 vaccines: development, effectiveness, adverse effects, distribution and challenges
Md. Mijanur Rahman, Md. Habib Ullah Masum, Shah Wajed, et al.
VirusDisease (2022) Vol. 33, Iss. 1, pp. 1-22
Open Access | Times Cited: 98

A review on current status of antiviral peptides
Abid Qureshi
Discover Viruses. (2025) Vol. 2, Iss. 1
Open Access | Times Cited: 1

SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic
Ali A. Rabaan, Shamsah H. Al-Ahmed, Ranjit Sah, et al.
Annals of Clinical Microbiology and Antimicrobials (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 134

COVID-19 Vaccine-Related Thrombosis: A Systematic Review and Exploratory Analysis
Clio Bilotta, Giulio Perrone, Valeria Adelfio, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 94

The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials
Jerome Amir Singh, Ross Upshur
The Lancet Infectious Diseases (2020) Vol. 21, Iss. 4, pp. e103-e109
Open Access | Times Cited: 83

Vaccines for COVID-19 - state of the art
Eduardo Jorge da Fonseca Lima, Amália Mapurunga Almeida, Renato de Ávila Kfouri
Revista Brasileira de Saúde Materno Infantil (2021) Vol. 21, Iss. suppl 1, pp. 13-19
Open Access | Times Cited: 77

SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists
Roberta Priori, Greta Pellegrino, Serena Colafrancesco, et al.
Annals of the Rheumatic Diseases (2021) Vol. 80, Iss. 7, pp. 953-954
Closed Access | Times Cited: 70

The global transmission of new coronavirus variants
Yingjie Zhao, Jianping Huang, Li Zhang, et al.
Environmental Research (2021) Vol. 206, pp. 112240-112240
Open Access | Times Cited: 68

Bacterial membrane vesicles for vaccine applications
Nishta Krishnan, Luke J. Kubiatowicz, Maya Holay, et al.
Advanced Drug Delivery Reviews (2022) Vol. 185, pp. 114294-114294
Open Access | Times Cited: 64

COVID-19 vaccine research focusses on safety, efficacy, immunoinformatics, and vaccine production and delivery: a bibliometric analysis based on VOSviewer
Yamin Chen, Luying Cheng, Rongna Lian, et al.
BioScience Trends (2021) Vol. 15, Iss. 2, pp. 64-73
Open Access | Times Cited: 63

Page 1 - Next Page

Scroll to top